Brief: Lumc To Fund New Clinical Trial Of Cynata's Cymerus Mscs In Kidney Transplantation
04/11/2022 10:10
Nov 4 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* LUMC TO FUND NEW CLINICAL TRIAL OF CYNATA'S CYMERUS™ MSCS
IN
KIDNEY TRANSPLANTATION
Source text for Eikon: ID:nPn2TCKqga
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million